CD80 and neoplasm: It has been shown that the CD80 surface molecule preferentially engages with the inhibitory protein cytotoxic T-lymphocyte associated protein 4 (CTLA4) on T-lymphocytes, leading to immune exhaustion and tumor growth [26,27].